Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 1, 2012
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - Market Wire
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - Market Wire
[ Tue, May 01st 2012
] - Market Wire
[ Tue, May 01st 2012
] - Market Wire
[ Tue, May 01st 2012
] - Market Wire
[ Tue, May 01st 2012
] - Market Wire
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
Christopher Raymond Maintained (BIIB) at Buy with Increased Target to $159 on, May 1st, 2012
Christopher Raymond of Piper Sandler, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $140 to $159 on, May 1st, 2012.
Christopher has made no other calls on BIIB in the last 4 months.
There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, 0 agree with Christopher's Rating of Hold.
This is the rating of the analyst that currently disagrees with Christopher
- Matthew Harrison of "Morgan Stanley" Initiated at Buy and Held Target at $140 on, Friday, February 10th, 2012
Similar Stocks and Investing Articles
[ Fri, Apr 27th 2012
] - WOPRAI
[ Fri, Apr 27th 2012
] - WOPRAI
[ Wed, Apr 25th 2012
] - WOPRAI
[ Thu, Apr 19th 2012
] - WOPRAI
[ Thu, Apr 19th 2012
] - WOPRAI
[ Wed, Apr 11th 2012
] - WOPRAI
[ Tue, Apr 10th 2012
] - WOPRAI
[ Tue, Mar 27th 2012
] - WOPRAI
[ Mon, Mar 19th 2012
] - WOPRAI
[ Tue, Mar 06th 2012
] - WOPRAI